VJHemOnc is committed to improving our service to you

iwNHL 2019 | Possibilities for the use of pembrolizumab in lymphoma treatment

VJHemOnc is committed to improving our service to you

John Kuruvilla

John Kuruvilla, MD, FRCPC, Princess Margaret Cancer Centre, Toronto, ON, Canada, speaking at the 17th International Workshop on Non-Hodgkin Lymphoma, Boston, MA, discusses the use of pembrolizumab in the treatment of varying lymphomas. Dr Kuruvilla discusses the parallels between Hodgkin lymphoma and primary mediastinal lymphoma, and suggests an increase in usage of the drug as treatment for Richter transformation, CNS disease, and testicular involvement.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter